Semanteon Capital Management LP Makes New $1.44 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Semanteon Capital Management LP acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,427 shares of the biotechnology company’s stock, valued at approximately $1,442,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC increased its stake in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at about $40,000. Brooklyn Investment Group purchased a new stake in Axon Enterprise in the 3rd quarter valued at about $41,000. Y.D. More Investments Ltd purchased a new stake in Axon Enterprise in the 4th quarter valued at about $45,000. Finally, Stonebridge Financial Group LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at about $53,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock valued at $1,087,843 in the last three months. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Down 1.7 %

AXON opened at $558.41 on Friday. The company has a 50 day moving average of $592.10 and a 200 day moving average of $539.60. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a market cap of $42.79 billion, a PE ratio of 144.29, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Finally, Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.